Brokerages forecast that Integer Holdings Corp (NYSE:ITGR) will announce earnings of $0.92 per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Integer’s earnings. The highest EPS estimate is $0.93 and the lowest is $0.90. Integer reported earnings per share of $0.96 during the same quarter last year, which would suggest a negative year-over-year growth rate of 4.2%. The company is expected to issue its next quarterly earnings report on Thursday, February 28th.
According to Zacks, analysts expect that Integer will report full-year earnings of $3.66 per share for the current year. For the next year, analysts anticipate that the business will report earnings of $4.12 per share, with EPS estimates ranging from $4.06 to $4.18. Zacks’ earnings per share averages are an average based on a survey of research analysts that cover Integer.
Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, November 1st. The medical equipment provider reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.14. Integer had a net margin of 14.12% and a return on equity of 12.78%. The business had revenue of $305.10 million for the quarter, compared to analysts’ expectations of $301.95 million. During the same period last year, the business earned $0.91 EPS. The company’s revenue was up 6.6% compared to the same quarter last year.
ITGR stock traded down $1.54 during trading on Friday, reaching $83.76. The company had a trading volume of 197,572 shares, compared to its average volume of 161,470. The stock has a market capitalization of $2.76 billion, a PE ratio of 29.81 and a beta of 0.90. The company has a quick ratio of 1.32, a current ratio of 2.41 and a debt-to-equity ratio of 0.88. Integer has a twelve month low of $42.50 and a twelve month high of $90.03.
In other Integer news, Director Pamela G. Bailey sold 5,767 shares of the firm’s stock in a transaction that occurred on Tuesday, November 20th. The shares were sold at an average price of $83.16, for a total transaction of $479,583.72. Following the completion of the transaction, the director now directly owns 53,562 shares of the company’s stock, valued at approximately $4,454,215.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Joseph F. Flanagan sold 13,633 shares of the firm’s stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $86.42, for a total transaction of $1,178,163.86. Following the transaction, the executive vice president now directly owns 12,622 shares of the company’s stock, valued at $1,090,793.24. The disclosure for this sale can be found here. Insiders have sold a total of 32,330 shares of company stock valued at $2,796,821 over the last three months. 3.60% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Point72 Hong Kong Ltd purchased a new position in shares of Integer during the 2nd quarter valued at approximately $111,000. Federated Investors Inc. PA increased its holdings in shares of Integer by 236.3% during the 2nd quarter. Federated Investors Inc. PA now owns 2,411 shares of the medical equipment provider’s stock valued at $156,000 after purchasing an additional 1,694 shares in the last quarter. C M Bidwell & Associates Ltd. purchased a new position in shares of Integer during the 3rd quarter valued at approximately $219,000. BlueMountain Capital Management LLC purchased a new position in shares of Integer during the 2nd quarter valued at approximately $194,000. Finally, South State Corp purchased a new position in shares of Integer during the 2nd quarter valued at approximately $200,000. 96.15% of the stock is owned by institutional investors.
Integer Company Profile
Integer Holdings Corp. engages in manufacturing and developing medical devices and components. It operates through Medical and Non-Medical segments. The Medical segment include cardio and vascular; cardiac and neuromodulation; and advanced surgical, orthopedics, and portable medical. The Non-Medical segment focuses on lithium cells, and primary and secondary battery packs for applications in the energy, military and environmental markets.The company was founded by Wilson Greatbatch in 1970 and is headquartered in Frisco, TX.
Featured Story: 52-Week High/Low
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.